Clinical Trial Update: Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on alemtuzumab (CAMPATH-1H) given with G-CSF in adults with refractory acute lymphoblastic leukemia; the Phase 1/2 study is reported as co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED